🔗 Full article: lnkd.in/eFWBhtze
ℹ️ More information on the LIQPLAT trial: liqplat.com
🔗 Full article: lnkd.in/eFWBhtze
ℹ️ More information on the LIQPLAT trial: liqplat.com
The Swiss HIV Cohort Study (#SHCS) — a well-established, nationwide cohort — has now implemented the TwiCs design for the first time in Switzerland.
The Swiss HIV Cohort Study (#SHCS) — a well-established, nationwide cohort — has now implemented the TwiCs design for the first time in Switzerland.
Co-author @schwenkej.bsky.social found industry-sponsored trials were more often completed and available.
🔗 Read the study: ja.ma/41I2etz
@peerreviewcongress.bsky.social
Co-author @schwenkej.bsky.social found industry-sponsored trials were more often completed and available.
🔗 Read the study: ja.ma/41I2etz
@peerreviewcongress.bsky.social
@schwenkej.bsky.social @clinepi-basel.bsky.social
@unibas.ch @mcmasteruniversity.bsky.social
#OpenScience #MetaResearch #PeerReview
@schwenkej.bsky.social @clinepi-basel.bsky.social
@unibas.ch @mcmasteruniversity.bsky.social
#OpenScience #MetaResearch #PeerReview
Older teens (15–17) most affected: girls → more mental health issues, boys → more substance use.
Yet only 17% accessed care.
Urgent need for youth-friendly services.
Read more:
onlinelibrary.wiley.com/doi/10.1111/...
Older teens (15–17) most affected: girls → more mental health issues, boys → more substance use.
Yet only 17% accessed care.
Urgent need for youth-friendly services.
Read more:
onlinelibrary.wiley.com/doi/10.1111/...
📝 Community-Based chronic Care Lesotho (ComBaCaL) cohort profile
a cohort of 14,700+ people in rural Lesotho, uncovering the intersection of chronic disease, poverty, & care access.
📝 Community-Based chronic Care Lesotho (ComBaCaL) cohort profile
a cohort of 14,700+ people in rural Lesotho, uncovering the intersection of chronic disease, poverty, & care access.
💭 The team is currently looking for funding to implement a pilot - ideas welcome!
Read more here: bmcpublichealth.biomedcentral.com/articles/10....
💭 The team is currently looking for funding to implement a pilot - ideas welcome!
Read more here: bmcpublichealth.biomedcentral.com/articles/10....
🔗Check out the link for the open access paper:
www.sciencedirect.com/science/arti...
@jclinepi.bsky.social @unibas.ch @dkf.unibas.ch @snsf.ch
🔗Check out the link for the open access paper:
www.sciencedirect.com/science/arti...
@jclinepi.bsky.social @unibas.ch @dkf.unibas.ch @snsf.ch
Read more 👉
Read more 👉
We just wrapped up an unforgettable summer event featuring fun quizzes & games and ending off with an exciting cooking challenge 🍴 A huge thank you to everyone who joined, competed and organised this event, we are already looking forward to the next one!
We just wrapped up an unforgettable summer event featuring fun quizzes & games and ending off with an exciting cooking challenge 🍴 A huge thank you to everyone who joined, competed and organised this event, we are already looking forward to the next one!
🔗Full publication@jclinepi.bsky.social : www.sciencedirect.com/science/arti...
🔗Full publication@jclinepi.bsky.social : www.sciencedirect.com/science/arti...
🔗: www.sciencedirect.com/science/arti...
🔗: www.sciencedirect.com/science/arti...
Felix Gerber will give a short presentation on digital innovation in low- and middle-income countries.
📅 Date: Thursday, 22 May 2025
🕘 Time: 09:00–17:30 CET
📍 Location: Campus Biotech, Geneva, Switzerland
🔗 Register here: gdhub.org/25gdhd/
Felix Gerber will give a short presentation on digital innovation in low- and middle-income countries.
📅 Date: Thursday, 22 May 2025
🕘 Time: 09:00–17:30 CET
📍 Location: Campus Biotech, Geneva, Switzerland
🔗 Register here: gdhub.org/25gdhd/
Clinical trials often face overoptimistic budgets and funding shortfalls, leading to costly trial discontinuations. We reviewed Swiss budgeting tools and found untested, inconsistent methods without prespecified cost ranges.
Article: trialsjournal.biomedcentral.com/articles/10....
Clinical trials often face overoptimistic budgets and funding shortfalls, leading to costly trial discontinuations. We reviewed Swiss budgeting tools and found untested, inconsistent methods without prespecified cost ranges.
Article: trialsjournal.biomedcentral.com/articles/10....
Full article: www.thelancet.com/journals/lan...
Full article: www.thelancet.com/journals/lan...
Findings suggested that JAK inhibitors reduced mortality across all levels of respiratory support
🔗 tinyurl.com/2hprv99v
Findings suggested that JAK inhibitors reduced mortality across all levels of respiratory support
🔗 tinyurl.com/2hprv99v
The event highlighted the importance of locally led, evidence-based research — now more critical than ever! 🩺📚
The event highlighted the importance of locally led, evidence-based research — now more critical than ever! 🩺📚
Join us at the @swisstph.ch on June 3, 2025 (2:00 PM – 5:00 PM) for a discussion with experts from @columbiauniversity.bsky.social , @uzh-ch.bsky.social, @swisstph.ch , and University Hospital Basel!
🔗 RSVP: nat.johnson@unibas.ch
Join us at the @swisstph.ch on June 3, 2025 (2:00 PM – 5:00 PM) for a discussion with experts from @columbiauniversity.bsky.social , @uzh-ch.bsky.social, @swisstph.ch , and University Hospital Basel!
🔗 RSVP: nat.johnson@unibas.ch
March 26th, Prof. @stephensenn.bsky.social will travel to #Basel and give a presentation on methodology and statistics in #RCTs. He will share his insights on why we randomize trials, the value of balance, whether trials should be representative, and much more.
March 26th, Prof. @stephensenn.bsky.social will travel to #Basel and give a presentation on methodology and statistics in #RCTs. He will share his insights on why we randomize trials, the value of balance, whether trials should be representative, and much more.
We found a probable dementia prevalence of 5% in Lesotho, aligning with regional estimates for Africa. 🧠
alz-journals.onlinelibrary.wiley.com/doi/10.1002/...
We found a probable dementia prevalence of 5% in Lesotho, aligning with regional estimates for Africa. 🧠
alz-journals.onlinelibrary.wiley.com/doi/10.1002/...
Check out the full cohort profile here: bmjopen.bmj.com/content/15/2...
Check out the full cohort profile here: bmjopen.bmj.com/content/15/2...
🧵 (1/4)
🧵 (1/4)